Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05283811 · ClinicalTrials.gov registry record · NA

Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients

A NA study of Epilepsy, sponsored by Baylor College of Medicine.

Recruiting
Registry status
NA
Development phase
205
Enrollment target
3
Study locations

NCT05283811: Recruiting NA study of Epilepsy, sponsored by Baylor College of Medicine.

NCT05283811 is a NA study of Epilepsy that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 205 participants, below the 951-participant average among 160 other Epilepsy trials with a reported enrollment target (78% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05283811, a NA study of Epilepsy, is actively recruiting participants, sponsored by Baylor College of Medicine.

RECRUITING
Registry status
NA
Development phase
205 participants
Enrollment target
3
Study locations

Study Summary

Humans have a remarkable ability to flexibly interact with the environment. A compelling demonstration of this cognitive flexibility is human's ability to respond correctly to novel contextual situations on the first attempt, without prior rehearsal. The investigators refer to this ability as 'ad hoc self-programming': 'ad hoc' because these new behavioral repertoires are cobbled together on the fly, based on immediate demand, and then discarded when no longer necessary; 'self-programming' because the brain has to configure itself appropriately based on task demands and some combination of prior experience and/or instruction. The overall goal of our research effort is to understand the neurophysiological and computational basis for ad hoc self-programmed behavior. The previous U01 project (NS 108923) focused on how these programs of action are initially created. The results thus far have revealed tantalizing notions of how the brain represents these programs and navigates through the programs. In this proposal, therefore, the investigators focus on the question of how these mental programs are executed. Based on the preliminary findings and critical conceptual work, the investigators propose that the medial temporal lobe (MTL) and ventral prefrontal cortex (vPFC) creates representations of the critical elements of these mental programs, including concepts such as 'rules' and 'locations', to allow for effective navigation through the algorithm. These data suggest the existence of an 'algorithmic state space' represented in medial temporal and prefrontal regions. This proposal aims to understand the neurophysiological underpinnings of this algorithmic state space in humans. By studying humans, the investigators will profit from our species' powerful capacity for generalization to understand how such state spaces are constructed. The investigators therefore leverage the unique opportunities available in human neuroscience research to record from single cells and popula

Primary Outcome

Patients will be asked to perform a few different novel, computerized tasks where the patients must respond to on-screen stimuli using button presses. Behavior will be assessed in terms of the accuracy of these responses.

Conditions Studied

Interventions

  • DEVICE NEUROPACE RNS SYSTEM
  • BEHAVIORAL EMU

Study Locations (3)

California

  • University of California, Los Angeles - Los Angeles

Texas

  • Baylor College of Medicine - Houston

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 205 participants
Start Date 2021-06-01
Est. Completion 2026-03-31
Phase NA
Baylor College of Medicine

616 total trials

What NCT05283811 shows while recruiting

NCT05283811 is an interventional study that assigns participants to a tested intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap, below the 951-participant average among 160 other Epilepsy trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which NEUROPACE RNS SYSTEM is the first listed.

NCT05283811 reports a single indexed study location in California, Texas, Utah.

Frequently Asked Questions

What is clinical trial NCT05283811 about?

NCT05283811 is a clinical study titled "Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients". Humans have a remarkable ability to flexibly interact with the environment. A compelling demonstration of this cognitive flexibility is human's ability to respond correctly to novel contextual situations on the first attempt, without prior rehearsal. The investigators refer to this ability as 'ad ho...

What is the current status of trial NCT05283811?

This trial is currently recruiting. It is a NA study. The enrollment target is 205 participants. The study started on 2021-06-01. Estimated completion is 2026-03-31.

What conditions does trial NCT05283811 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT05283811?

The interventions under investigation include: NEUROPACE RNS SYSTEM (DEVICE), EMU (BEHAVIORAL).

Who is sponsoring clinical trial NCT05283811?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05283811 being conducted?

This trial has 3 study locations across California, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05283811's enrollment target sits among peer trials

205 30th of 160 higher than 131 of 160 other Epilepsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03457493 · 205 participants · Phase 1

    The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

  • NCT05134857 · 205 participants · Phase 2

    The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

  • NCT05181891 · 205 participants · Phase 2

    Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

  • NCT05304585 · 205 participants · Phase 3

    Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05283811, the US trial registry maintained by the National Library of Medicine. NCT05283811 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.